Five Year Outcomes from Acute Lung Injury

急性肺损伤的五年结果

基本信息

  • 批准号:
    8126292
  • 负责人:
  • 金额:
    $ 19.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-11 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Acute Lung Injury (ALI) is a syndrome characterized by acute, diffuse pulmonary capillary leak resulting in hypoxic respiratory failure. ALI imposes a significant public health burden with an incidence of 86 per 100,000 person years and a total number of deaths similar to breast cancer or HIV infection. Due to advances in medical care, the mortality rate for ALI has decreased from -70% to -40%. Patients who previously may have died now survive ALI; however, their recovery is often long and complicated. Research studying the long-term outcomes of these ALI survivors has become increasingly important. The present application is a third submission for a K24 award. The PI is a leader is patient -oriented research in critically ill patients especially those with ALI, and has an outstanding record of mentoring trainees. The goal of this proposal is to learn how existing ICU therapies can be used to minimize long-term physical and mental health morbidities and improve patients' functional status and quality of life after ALI. We propose to extend our existing NIH funded cohort study, which follows patients for 2 years after ALI, to allow 5-year follow-up. Specifically, we will study the epidemiology of muscle weakness, and symptoms of anxiety, depression and post-traumatic stress disorder at up to 5 years after ALI [Aims 1a and 2a] and the association of these sequelae with limitations in patients' physical function and quality of life. We will then determine the association of nutrition and corticosteroids in the ICU with long-term muscle weakness[Aim 1b]. We also will determine the association of delirium and corticosteroids in the ICU with long-term symptoms of post-traumatic stress disorder [Aim 2b]. A number of research opportunities exist for trainees. This research proposal describes a new cohort study of ALI patients who will be followed for 5 years. This research will provide new knowledge regarding the frequency of morbidities after ALI, their consequences for patients, and how nutrition, corticosteroids and delirium in the ICU may reduce or exacerbate these morbidities up to 5 years after ALI. The study will add to our infrastructure for trainees to participate in clinical research and to design future studies, including intervention studies, to improve outcomes in ALI patients. RELEVANCE (See instructions): Acute lung injury is a significant public health problem that can lead to death or long-term physical and mental illnesses. While death rates have been decreased by advances in medical care, the recovery period from ALI is long and patients are left with significant morbidity. This grant would research existing ICU therapies that could improve recovery and reduce long-term physical and mental health morbidities from ALI.
描述(由申请人提供):急性肺损伤(ALI)是一种综合征,其特征是急性,弥漫性肺毛细管泄漏,导致低氧呼吸衰竭。阿里施加了重大的公共卫生负担,每100,000人的发生率为86,与乳腺癌或艾滋病毒感染相似的死亡人数总数为86。由于医疗保健的进步,ALI的死亡率已从-70%降至-40%。以前可能已经死亡的患者现在幸存下来。但是,他们的恢复通常很长而复杂。研究这些ALI幸存者的长期结果的研究变得越来越重要。本申请是K24奖励的第三份提交。 PI是领导者,是针对危重患者尤其是患有ALI的患者的患者研究,并且具有出色的指导学员记录。该建议的目的是了解如何使用现有的ICU疗法来最大程度地减少长期身心健康的病态,并改善患者在ALI之后的功能状况和生活质量。我们建议扩展我们现有的NIH资助的队列研究,该研究跟随患者在ALI之后2年,以进行5年的随访。具体而言,我们将研究肌肉无力的流行病学,以及在ALI后5年的焦虑,抑郁和创伤后应激障碍的症状[AIMS 1A和2A],以及这些后遗症与患者身体功能和生活质量的限制之间的关联。然后,我们将确定ICU中的营养和皮质类固醇与长期肌肉无力的关联[AIM 1B]。我们还将确定ICU中del妄和皮质类固醇与创伤后应激障碍的长期症状的关联[AIM 2B]。学员存在许多研究机会。这项研究建议描述了一项新的队列研究,对ALI患者进行了5年的追踪。这项研究将提供有关ALI后病原体的频率,对患者的后果以及ICU中​​的营养,皮质类固醇和del妄如何减少或加剧这些病态后5年后的营养,皮质类固醇和ir妄,最多可在ALI后5年减少或加剧这些病态。这项研究将增加我们的基础设施,以供受训者参与临床研究并设计包括干预研究在内的未来研究,以改善ALI患者的预后。相关性(请参阅说明):急性肺损伤是一个重大的公共卫生问题,可能导致死亡或长期的身体和精神疾病。尽管医疗保健的进展降低了死亡率,但阿里的恢复期很长,患者的发病率很高。这项赠款将研究现有的ICU疗法,这些疗法可以改善恢复并减少ALI的长期身心健康。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter J. Pronovost其他文献

Aspiration Pneumonia: Mixing Apples with Oranges and Tangerines [1] (multiple letters)
吸入性肺炎:将苹果与橙子和橘子混合[1](多个字母)
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    P. Marik;S. Berenholtz;Jeff H. Kozlow;Todd Dorman;Peter J. Pronovost
  • 通讯作者:
    Peter J. Pronovost
Application of Information Technology: Creating the Web-based Intensive Care Unit Safety Reporting System
信息技术的应用:创建基于网络的重症监护室安全报告系统
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    C. Holzmueller;Peter J. Pronovost;Fern Dickman;David A. Thompson;Albert W. Wu;L. Lubomski;M. Fahey;Donald M. Steinwachs;Lilly Engineer;A. Jaffrey;L. Morlock;Todd Dorman
  • 通讯作者:
    Todd Dorman
Operating room debriefings.
手术室情况汇报。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    M. Makary;C. Holzmueller;J. B. Sexton;David A. Thompson;Elizabeth A. Martinez;J. Freischlag;John A. Ulatowski;E. Heitmiller;L. Rowen;Peter J. Pronovost
  • 通讯作者:
    Peter J. Pronovost
Frailty, hospital volume, and failure to rescue after head and neck cancer surgery
头颈癌手术后的虚弱、住院量和抢救失败
  • DOI:
    10.1002/lary.26952
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Carrie L. Nieman;C. Matthew Stewart;D. Eisele;Peter J. Pronovost;C. Gourin
  • 通讯作者:
    C. Gourin
Demonstrating high reliability on accountability measures at the Johns Hopkins Hospital.
约翰·霍普金斯医院的问责措施表现出高度可靠性。
  • DOI:
    10.1016/s1553-7250(13)39069-2
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Peter J. Pronovost;Peter J. Pronovost;Renee Demski;Renee Demski;T. Callender;L. Winner;Marlene R. Miller;Marlene R. Miller;Marlene R. Miller;J. M. Austin;J. M. Austin;S. Berenholtz;Cora Abundo;Sharon Allen;Marc Applestein;Walt Atha;Kelly Baca;Deborah Baker;Jennifer Baxter;Ed Bessman;Michael Brinkman;Judy Brown;Tanya Brown;Barbara Bryant;Brendan Carmody;Karen Carroll;Bridget Carver;Jennifer Castellani;Yang Ho Choi;Cathy Clarke;Mel Coker;Margareta Cuccia;Ruth Dalgetty;Richard Day;Andrea DelRosario;Katherine Deruggiero;Denice L. Duda;Robert A Dudas;John Dunn;Damon Duquaine;Joe Dwyer;Alexis Edwards;Deirdre Flowers;Cathy Garger;K. Goldsborough;Susan Groman;Felix Guzman;Leslie Hack;Margie Hackett;Laura Hagan;Judith Haynos;Elizabeth Heck;Genie Heitmiller;P. Hill;Ann Hoffman;Keith Horvath;Roberta Jensen;Peter Johnson;Ilene Jonas;Kimberly Kelly;Terri Kemmerer;Salwa Khan;Mark Landrum;Barton Leonard;Karen Lieberman;Jackie Lobien;C. Maritim;Giuliana Markovich;Bernard Marquis;Blanka McClammer;Deborah McDonough;Barbara McGuiness;Janet McIntyre;Danielle McQuigg;Melissa Means;Karen Michaels;Julie Miller;Vicki Minor;Regina Morton;Jennifer Moyer;Hilda Nimako;Sharon Owens;Eric Park;Judith Peck;Peter Petrucci;Brent G. Petty;Marcy Post;Sarah Rasmussen;Jennifer Raynor;Joanne Renjel;Jon Resar;Sharon Rossi;L. Rotello;Stuart Russell;M. Saheed;Jacky Schultz;Paige Schwartz;K. Servis;Amanda Shrout;LeighAnn Sidone;Nancy Smith;Rita Smith;Tracey Smith;Evelyn St. Martin;E. Taffe;Cynthia Thomas;T. Tolson;Jeff Trost;Cynthia Walters;Carol Ware;Robin Wessels;Glen Whitman;Chet Wyman
  • 通讯作者:
    Chet Wyman

Peter J. Pronovost的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter J. Pronovost', 18)}}的其他基金

Applying Human Factors and Mathematical Modeling Approaches to Prevent Transmission of High-Consequence Pathogens
应用人为因素和数学建模方法来防止高后果病原体的传播
  • 批准号:
    9075150
  • 财政年份:
    2015
  • 资助金额:
    $ 19.57万
  • 项目类别:
Transdisciplinary Learning Lab to eliminate patient harm and reduce waste
跨学科学习实验室消除患者伤害并减少浪费
  • 批准号:
    8804327
  • 财政年份:
    2014
  • 资助金额:
    $ 19.57万
  • 项目类别:
Transdisciplinary Learning Lab to eliminate patient harm and reduce waste
跨学科学习实验室消除患者伤害并减少浪费
  • 批准号:
    8932017
  • 财政年份:
    2014
  • 资助金额:
    $ 19.57万
  • 项目类别:
Transdisciplinary Learning Lab to eliminate patient harm and reduce waste
跨学科学习实验室消除患者伤害并减少浪费
  • 批准号:
    9143137
  • 财政年份:
    2014
  • 资助金额:
    $ 19.57万
  • 项目类别:
Translating CER results from ICU study to improve outcomes in cardiac surgery
将 ICU 研究的 CER 结果转化为改善心脏手术的结果
  • 批准号:
    8309774
  • 财政年份:
    2010
  • 资助金额:
    $ 19.57万
  • 项目类别:
Translating CER results from ICU study to improve outcomes in cardiac surgery
将 ICU 研究的 CER 结果转化为改善心脏手术的结果
  • 批准号:
    8146868
  • 财政年份:
    2010
  • 资助金额:
    $ 19.57万
  • 项目类别:
Translating CER results from ICU study to improve outcomes in cardiac surgery
将 ICU 研究的 CER 结果转化为改善心脏手术的结果
  • 批准号:
    8053133
  • 财政年份:
    2010
  • 资助金额:
    $ 19.57万
  • 项目类别:
Five Year Outcomes from Acute Lung Injury
急性肺损伤的五年结果
  • 批准号:
    8523195
  • 财政年份:
    2009
  • 资助金额:
    $ 19.57万
  • 项目类别:
Five Year Outcomes from Acute Lung Injury
急性肺损伤的五年结果
  • 批准号:
    7588191
  • 财政年份:
    2009
  • 资助金额:
    $ 19.57万
  • 项目类别:
Five Year Outcomes from Acute Lung Injury
急性肺损伤的五年结果
  • 批准号:
    8318162
  • 财政年份:
    2009
  • 资助金额:
    $ 19.57万
  • 项目类别:

相似国自然基金

DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
  • 批准号:
    82374186
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
  • 批准号:
    82302445
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
  • 批准号:
    82374400
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目

相似海外基金

New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists
严重Covid-19和病毒性过度炎症损伤的新靶点和新疗法:肾酶和肾酶激动剂
  • 批准号:
    10759030
  • 财政年份:
    2023
  • 资助金额:
    $ 19.57万
  • 项目类别:
DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD)
DLL4 在发育中的肺和支气管肺发育不良 (BPD) 中的作用
  • 批准号:
    10584811
  • 财政年份:
    2023
  • 资助金额:
    $ 19.57万
  • 项目类别:
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation
Siltuximab 治疗肺移植后抗体介导的排斥反应的 1 期临床试验
  • 批准号:
    10714920
  • 财政年份:
    2023
  • 资助金额:
    $ 19.57万
  • 项目类别:
Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
  • 批准号:
    10750085
  • 财政年份:
    2023
  • 资助金额:
    $ 19.57万
  • 项目类别:
Cellular and molecular mechanisms of e-cigarette vaping-induced acute lung injury
电子烟引起急性肺损伤的细胞和分子机制
  • 批准号:
    10690279
  • 财政年份:
    2022
  • 资助金额:
    $ 19.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了